"beta-Galactosidase/administration and dosage"[MAJR] - Search Results

Year	Number of Results
1977	1
1978	2
1984	2
1985	3
1987	1
1988	1
1990	1
1991	3
1992	1
1993	1
1998	2
2000	1
2001	2
2002	1
2004	1
2005	2
2006	1
2007	1
2010	4
2011	2
2012	2
2013	3
2014	4
2015	2
2016	1
2018	1
2019	1
2020	2
2024	0

1

A carrier for non-covalent delivery of functional beta-galactosidase and antibodies against amyloid plaques and IgM to the brain.

Sarkar G, Curran GL, Mahlum E, Decklever T, Wengenack TM, Blahnik A, Hoesley B, Lowe VJ, Poduslo JF, Jenkins RB. Sarkar G, et al. PLoS One. 2011;6(12):e28881. doi: 10.1371/journal.pone.0028881. Epub 2011 Dec 21. PLoS One. 2011. PMID: 22216132 Free PMC article.

2

Enzymatic removal of alphaGal antigen in pig kidneys by ex vivo and in vivo administration of endo-beta-galactosidase C.

Liu D, Kobayashi T, Yokoyama I, Ogawa H, Nagasaka T, Muramatsu H, Kadomatsu K, Oikawa T, Shimano Y, Morozumi K, Uchida K, Muramatsu T, Nakao A. Liu D, et al. Xenotransplantation. 2002 May;9(3):228-36. doi: 10.1034/j.1399-3089.2002.01068.x. Xenotransplantation. 2002. PMID: 11983021

3

Pharmacokinetics and pharmacodynamics of JR-051, a biosimilar of agalsidase beta, in healthy adults and patients with Fabry disease: Phase I and II/III clinical studies.

Nakamura K, Kawashima S, Tozawa H, Yamaoka M, Yamamoto T, Tanaka N, Yamamoto R, Okuyama T, Eto Y. Nakamura K, et al. Mol Genet Metab. 2020 Jul;130(3):215-224. doi: 10.1016/j.ymgme.2020.04.003. Epub 2020 May 1. Mol Genet Metab. 2020. PMID: 32389574 Free article. Clinical Trial.

4

DNA-Mediated Cellular Delivery of Functional Enzymes.

Brodin JD, Sprangers AJ, McMillan JR, Mirkin CA. Brodin JD, et al. J Am Chem Soc. 2015 Dec 2;137(47):14838-41. doi: 10.1021/jacs.5b09711. Epub 2015 Nov 20. J Am Chem Soc. 2015. PMID: 26587747 Free PMC article.

5

In vitro study of microencapsulated isoflavone and beta-galactosidase.

Kim NC, Jeon BJ, Ahn J, Kwak HS. Kim NC, et al. J Agric Food Chem. 2006 Apr 5;54(7):2582-6. doi: 10.1021/jf052369j. J Agric Food Chem. 2006. PMID: 16569047

6

Milking gene therapy.

Alton EW, Griesenbach U, Geddes DM. Alton EW, et al. Nat Med. 1998 Oct;4(10):1121-2. doi: 10.1038/2616. Nat Med. 1998. PMID: 9771739 No abstract available.

7

Use of a Novel Probiotic Formulation to Alleviate Lactose Intolerance Symptoms-a Pilot Study.

Gingold-Belfer R, Levy S, Layfer O, Pakanaev L, Niv Y, Dickman R, Perets TT. Gingold-Belfer R, et al. Probiotics Antimicrob Proteins. 2020 Mar;12(1):112-118. doi: 10.1007/s12602-018-9507-7. Probiotics Antimicrob Proteins. 2020. PMID: 30617948

8

Enzyme delivery using the 30Kc19 protein and human serum albumin nanoparticles.

Lee HJ, Park HH, Kim JA, Park JH, Ryu J, Choi J, Lee J, Rhee WJ, Park TH. Lee HJ, et al. Biomaterials. 2014 Feb;35(5):1696-704. doi: 10.1016/j.biomaterials.2013.11.001. Epub 2013 Nov 18. Biomaterials. 2014. PMID: 24262100

9

Protein nanoparticles for intracellular delivery of therapeutic enzymes.

Estrada LH, Chu S, Champion JA. Estrada LH, et al. J Pharm Sci. 2014 Jun;103(6):1863-71. doi: 10.1002/jps.23974. Epub 2014 Apr 16. J Pharm Sci. 2014. PMID: 24740820

10

Enzyme replacement therapy for primary adult lactase deficiency. Effective reduction of lactose malabsorption and milk intolerance by direct addition of beta-galactosidase to milk at mealtime.

Rosado JL, Solomons NW, Lisker R, Bourges H. Rosado JL, et al. Gastroenterology. 1984 Nov;87(5):1072-82. Gastroenterology. 1984. PMID: 6434367 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

47 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

47 results

Results by year